Please provide evidence of this because I'm seeing quite the opposite. Cyrus would not have left his previous employer to jump on a ship with a 'For Sale' sign. He wouldn't be adding to the SAB and he wouldn't be focused on developing new protocols for future NASH and oncology trials. I'm not saying an acquisition is out of the question, but I don't see selling the company as his primary objective. Partnerships, yes - acquisitions, no.

Quote:

---

Remember, this management team was built to sell the company, not advance trials.

---